These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37746404)

  • 1. Multifocal Abscesses, Necrotizing Fasciitis, Iron Deficiency Anemia, and Hypophosphatemia Induced by Ferric Carboxymaltose Infusions: Report of a Case of Hereditary Hemorrhagic Telangiectasia.
    Trevise LA; Lopes Vieira Pinto MP; Hasselmann G; Lammoglia BC; Leal TP; Salles Rosa Neto N
    Cureus; 2023 Aug; 15(8):e44020. PubMed ID: 37746404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.
    Solela G; Adamseged M; Mohammed A
    Clin Case Rep; 2023 Jul; 11(7):e7694. PubMed ID: 37448947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    Wolf M; Rubin J; Achebe M; Econs MJ; Peacock M; Imel EA; Thomsen LL; Carpenter TO; Weber T; Brandenburg V; Zoller H
    JAMA; 2020 Feb; 323(5):432-443. PubMed ID: 32016310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report.
    Khan AR; Waqar S; Wazir MH; Arif A
    Cureus; 2022 Apr; 14(4):e24517. PubMed ID: 35651452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review.
    Bazeley JW; Wish JB
    Am J Kidney Dis; 2022 Jun; 79(6):868-876. PubMed ID: 34758368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Hemorrhagic Telangiectasia: A Rare Cause of Anemia.
    Jan W; Tameez Ud Din A; Chaudhary FMD; Tameez-Ud-Din A; Nawaz F
    Cureus; 2019 Aug; 11(8):e5349. PubMed ID: 31602353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside.
    Detlie TE; Lindstrøm JC; Jahnsen ME; Finnes E; Zoller H; Moum B; Jahnsen J
    Aliment Pharmacol Ther; 2019 Aug; 50(4):397-406. PubMed ID: 31264261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.
    Emrich IE; Lizzi F; Siegel JD; Seiler-Mussler S; Ukena C; Kaddu-Mulindwa D; D'Amelio R; Wagenpfeil S; Brandenburg VM; Böhm M; Fliser D; Heine GH
    BMC Med; 2020 Jul; 18(1):178. PubMed ID: 32654663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of intravenous iron-induced hypophosphatemia.
    Wolf M; Chertow GM; Macdougall IC; Kaper R; Krop J; Strauss W
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
    Fleagle JM; Bobba RK; Kardinal CG; Freter CE
    Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of parental iron-induced persistent hypophosphatemia.
    Sullivan A; Lanham T; Rubin A
    J Community Hosp Intern Med Perspect; 2020 May; 10(2):166-167. PubMed ID: 32850057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations.
    Nishioka Y; Akamatsu N; Sugawara Y; Kaneko J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
    Case Rep Med; 2015; 2015():917818. PubMed ID: 26078760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypophosphatemia following the administration of intravenous iron formulations: A case report and literature review].
    Lecoq AL; Dong C; Carbonnel F; Becquemont L
    Therapie; 2021; 76(6):705-714. PubMed ID: 33962799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteomalacia following intravenous iron suppletion].
    Koks N; Donga E; Appelman-Dijkstra NM
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.
    Mrzljak A; Popić J; Ožanić Bulić S
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):56-57. PubMed ID: 34477067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of hereditary hemorrhagic telangiectasia and literature review.
    Han Y; Ding B; Li M; Song X; Liu L; Zhou H
    J Clin Lab Anal; 2022 Aug; 36(8):e24571. PubMed ID: 35754156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia.
    Cavalcoli F; Gandini A; Matelloni IA; Catalano F; Alicante S; Manfredi G; Brambilla G; Menozzi F; Perolini F; Costi E; Bertè R; Buscarini E
    Orphanet J Rare Dis; 2020 Oct; 15(1):295. PubMed ID: 33081831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose.
    Fang W; McMahon LP; Bloom S; Garg M
    JGH Open; 2019 Oct; 3(5):438-440. PubMed ID: 31633052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.